PRECOSE Drug Patent Profile

Name: PRECOSE Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

« Back to Dashboard

Which patents cover Precose, and what generic alternatives are available?

Precose is a drug marketed by Bayer Hlthcare and is included in one NDA.

The generic ingredient in PRECOSE is acarbose. There is one drug master file entry for this compound. Six suppliers are listed for this compound. Additional details are available on the acarbose profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Precose

A generic version of PRECOSE was approved as acarbose by HIKMA on May 7^th, 2008.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for PRECOSE?
What are the global sales for PRECOSE?
What is Average Wholesale Price for PRECOSE?

Summary for PRECOSE

US Patents:	0
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	40
Clinical Trials:	8
Patent Applications:	24
Drug Prices:	Drug price information for PRECOSE
What excipients (inactive ingredients) are in PRECOSE?	PRECOSE excipients list
DailyMed Link:	PRECOSE at DailyMed

Drug patent expirations by year for PRECOSE

Recent Clinical Trials for PRECOSE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Montefiore Medical Center	Phase 2
Zhongda Hospital	Phase 4
University of British Columbia	Phase 2

See all PRECOSE clinical trials

Paragraph IV (Patent) Challenges for PRECOSE

Tradename	Dosage	Ingredient	Strength	NDA	ANDAs Submitted	Submissiondate
PRECOSE	Tablets	acarbose	25 mg, 50 mg and 100 mg	020482	1	2005-03-22

US Patents and Regulatory Information for PRECOSE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Bayer Hlthcare	PRECOSE	acarbose	TABLET;ORAL	020482-004	May 29, 1997		DISCN	Yes	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Bayer Hlthcare	PRECOSE	acarbose	TABLET;ORAL	020482-001	Sep 6, 1995		DISCN	Yes	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Bayer Hlthcare	PRECOSE	acarbose	TABLET;ORAL	020482-002	Sep 6, 1995		DISCN	Yes	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for PRECOSE

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Bayer Hlthcare	PRECOSE	acarbose	TABLET;ORAL	020482-004	May 29, 1997	4,904,769	⤷ Start Trial
Bayer Hlthcare	PRECOSE	acarbose	TABLET;ORAL	020482-002	Sep 6, 1995	4,904,769	⤷ Start Trial
Bayer Hlthcare	PRECOSE	acarbose	TABLET;ORAL	020482-001	Sep 6, 1995	4,904,769	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for PRECOSE

See the table below for patents covering PRECOSE around the world.

Subscribe to access the full database, or Start Trial
Country	Patent Number	Title	Estimated Expiration
Austria	71951		⤷ Start Trial
Bulgaria	49497	METHOD FOR PREPARING AKARBOZA	⤷ Start Trial
Canada	1288768	ACARBOSE TRES PUR (HIGHLY PURE ACARBOSE)	⤷ Start Trial
China	1013866		⤷ Start Trial
China	86108259		⤷ Start Trial
>Country	>Patent Number	>Title	>Estimated Expiration

DrugChatter Q&A for PRECOSE

Precose drug class?